StoneLab Inc.

StoneLab (스톤랩)

StoneLab

Company Profile: StoneLab Inc. (주)스톤랩
“Building the Foundation of Medical AI Solutions”

StoneLab Inc. is a digital health innovator specializing in Digital Diagnostics (DDx) and Digital Therapeutics (DTx). By combining proprietary vision AI technology with optical diagnostics, the company transforms traditional analog rapid tests into precise, quantitative digital data. Beyond diagnostics, StoneLab is expanding into chronic disease management and mental healthcare through its AI-driven platforms.

Field
Details
Global Name
StoneLab Inc.
CEO
Min-gu (BEric) Song
Headquarters
Daejeon, Republic of Korea (Offices in Seoul & Daegu)
Website
www.stonelab.kr
CES 2026 Location
Venetian Expo, Hall G
CES Detail Page
View on CES Website
Core Sectors
Bio-Health, AI Diagnostics, Digital Therapeutics, Point-of-Care Testing (POCT)
Executive Summary
Founded in 2020, StoneLab has rapidly established itself as a leader in the digitization of medical diagnostics. The company’s core competitiveness lies in its ability to provide lab-quality quantitative analysis using accessible, non-invasive rapid diagnostic tests (RDT/LFA) coupled with smartphone-based Vision AI. This technology democratizes access to precise healthcare data, enabling effective management of chronic conditions like cardiovascular and metabolic diseases.

In addition to diagnostics, StoneLab is pioneering Digital Therapeutics (DTx) with solutions like ARIA, which utilizes auditory stimuli for neuromodulation to address mental health challenges.
Key Products & Technologies
1. TESTAR: Vision AI Diagnostic Solution
* Description: A digital diagnostic solution that integrates optical technology with Vision AI to analyze Lateral Flow Assays (LFA) and other rapid tests.
* Key Features:
* High Precision: Achieves a Coefficient of Variation (CV) of < 5%, rivaling expensive benchtop analyzers.
* Hardware Agnostic: Compatible with various RDT brands and specifications, making it a versatile platform for diagnostic manufacturers without their own digital readers.
* Scanning Tech: "Scan-and-analyze" capability converts qualitative colorimetric data into semi-quantitative or quantitative numerical results.
2. TESTPLUS: DDx Management Platform
* Description: A comprehensive cloud-based platform for managing diagnostic data generated by TESTAR and other IVD devices.
* Function: Enables real-time monitoring, data visualization, and AI-driven interpretation for chronic disease management partnerships (e.g., with hospitals or insurance firms).
3. ARIA: Digital Therapeutics (DTx)
* Description: A prescription and non-prescription based solution focusing on mental healthcare and sleep optimization.
* Mechanism: Uses auditory-stimuli based neuromodulation to treat or manage cognitive and mental health conditions.
Company Milestones
* 2020: Company Foundation.
* 2021: Established AI Research Center.
* 2022: Launched FDA-cleared IVD Software (myHomeTest).
* 2023: Acquired ISO 9001, ISO 14001, and ISO 45001 certifications.
* 2024: Developed TESTAR prototype; conducted clinical validation for drug substance identification.
* Partnerships: Collaborating with Seoul National University Hospital (as noted in user context) to validate clinical utility and expand into chronic disease management.

Strategic Opportunities at CES 2026
The following exhibitors are identified as high-value targets for partnership, commercialization, or technological collaboration. They align with StoneLab’s focus on AI diagnostics, wearable health monitoring, and chronic disease management.
1. AI & Vision Diagnostics Partners
Companies leveraging AI for medical imaging and non-invasive health monitoring, offering potential for technical synergy or cross-licensing.

• AICU Inc.

• Relevance: Pioneers non-invasive healthcare using Vision AI to analyze bio-images for diagnosing conditions like dementia. Their approach to transforming everyday cameras into diagnostic tools mirrors StoneLab's TESTAR strategy.

• CES Page: View Details

• BIOPOP International Inc.

• Relevance: Revolutionizes health monitoring with non-invasive, real-time blood analysis using near-infrared spectroscopy. Potential synergy in multi-modal diagnostic platforms (optical + spectral).

• CES Page: View Details

• EX HEALTHCARE INC.

• Relevance: Specializes in medical AI solutions to enhance diagnostic accuracy. Their focus on integrating technology directly with patient care aligns with StoneLab's chronic disease management goals.

• CES Page: View Details

• Digital Health & Chronic Care Platforms
  Potential partners for the ARIA platform or TESTPLUS ecosystem, focusing on wellness, sleep, and metabolic health.

• Healthnix

• Relevance: Developed AI software for precision nutrition in chronic pain care. Their B2B medical focus aligns with StoneLab's DTx strategy for chronic conditions.

• CES Page: View Details

• UnoVins Inc.

• Relevance: Develops the UNOCARE platform, analyzing stress and autonomic nervous system activity. Highly relevant for collaboration with StoneLab's ARIA mental health solution.

• CES Page: View Details

• ViiRaa Inc (ViiRaa Wellness)

• Relevance: A behavior-change app blending Continuous Glucose Monitoring (CGM) with AI coaching. StoneLab’s diagnostics could serve as a complementary validation tool within their metabolic health programs.

• CES Page: View Details

• Global Healthcare Ecosystem & Standardization
  Organizations that can assist with US market entry, regulatory standards, and broad adoption.

• The Digital Medicine Society (DiMe)

• Relevance: A global non-profit driving adoption of digital medicine. Connecting with DiMe is crucial for StoneLab to establish TESTAR and ARIA as standardized digital endpoints in clinical trials and healthcare.
• CES Page: View Details

• Advanced Sensor & Hardware Tech
  Partners for miniaturizing or enhancing the physical diagnostic components.

• CSEM SA

• Relevance: A Swiss innovation center showcasing ultra-low-power smart systems for vital sign monitoring. Their expertise in optical sensors could enhance future iterations of TESTAR hardware.

• CES Page: View Details

• Gemss Healthcare Co., Ltd.

• Relevance: A global manufacturer of diagnostic imaging systems (C-arm, digital X-ray) with sales in 50 countries. A potential partner for bundling StoneLab’s software with hardware in hospital settings.

• CES Page: View Details